Association of rare MSH6 variants with familial breast cancer

Breast Cancer Research and Treatment

Volumn 123, Issue 2, 2010, Pages 315-320

  Wasielewski, Marijke ^a   Riaz, Muhammad ^a   Vermeulen, Joyce ^a   Van Den Ouweland, Ans ^a   Labrijn Marks, Ineke ^a   Olmer, Renske ^a   Van Der Spaa, Linda ^a   Klijn, Jan G M ^a   Meijers Heijboer, Hanne ^a   Dooijes, Dennis ^a   Schutte, Mieke ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

CHEK2 1100delC; Familial breast cancer; Hereditary breast and colorectal cancer; MSH6; Polygenic cancer susceptibility

Indexed keywords

CHECKPOINT KINASE 2; PROTEIN MSH6;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INTRONS; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; MUTATION; NETHERLANDS; PEDIGREE; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS;

EID: 77956192335     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0634-4     Document Type: Article

References (26)

1. H Meijers-Heijboer A van den Ouweland J Klijn, et al.. 2002 Low-penetrance susceptibility to breast cancer due to CHEK2()1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 55 59 10.1038/ng879 10.1038/ng879 1:CAS:528:DC%2BD38Xjt1Kns78%3D 11967536
2. P Vahteristo J Bartkova H Eerola, et al.. 2002 A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer Am J Hum Genet 71 432 438 10.1086/341943 10.1086/341943 1:CAS:528:DC%2BD38XlvV2qur8%3D 12094328
3. H Meijers-Heijboer J Wijnen H Vasen, et al.. 2003 The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype Am J Hum Genet 72 1308 1314 10.1086/375121 10.1086/375121 1:CAS:528:DC%2BD3sXjslagu7s%3D 12690581
4. M Wasielewski H Vasen J Wijnen, et al.. 2008 CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer Clin Cancer Res 14 4989 4994 10.1158/1078-0432.CCR-08-0389 10.1158/1078-0432.CCR-08-0389 1:CAS:528:DC%2BD1cXpt1eisLw%3D 18676774
5. JR Jass 2006 Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term World J Gastroenterol 12 4943 4950 1:CAS:528: DC%2BD28XhtVehtrbL 16937488
6. P Peltomaki 2005 Lynch syndrome genes Fam Cancer 4 227 232 10.1007/s10689-004-7993-0 10.1007/s10689-004-7993-0 16136382
7. HF Vasen G Moslein A Alonso, et al.. 2007 Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) J Med Genet 44 353 362 10.1136/jmg.2007.048991 10.1136/jmg.2007.048991 1:CAS:528: DC%2BD2sXnvFOisLo%3D 17327285
8. DW Bell JM Varley TE Szydlo, et al.. 1999 Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome Science 286 2528 2531 10.1126/science.286. 5449.2528 10.1126/science.286.5449.2528 1:CAS:528:DC%2BD3cXntlGh 10617473
9. SB Lee SH Kim DW Bell, et al.. 2001 Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome Cancer Res 61 8062 8067 1:CAS:528:DC%2BD3MXovVShsr8%3D 11719428
10. N Papadopoulos NC Nicolaides B Liu, et al.. 1995 Mutations of GTBP in genetically unstable cells Science 268 1915 1917 10.1126/science.7604266 10.1126/science.7604266 1:CAS:528:DyaK2MXms1Citb4%3D 7604266
11. P Vahteristo A Tamminen P Karvinen, et al.. 2001 p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition Cancer Res 61 5718 5722 1:CAS:528: DC%2BD3MXlvVCgtLw%3D 11479205
12. J Bartek J Lukas 2003 Chk1 and Chk2 kinases in checkpoint control and cancer Cancer Cell 3 421 429 10.1016/S1535-6108(03)00110-7 10.1016/S1535- 6108(03)00110-7 1:CAS:528:DC%2BD3sXktlyiurg%3D 12781359
13. JS Lee KM Collins AL Brown CH Lee JH Chung 2000 hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response Nature 404 201 204 10.1038/35004614 10.1038/35004614 1:CAS:528:DC%2BD3cXhvFOitb0%3D 10724175
14. Y Wang D Cortez P Yazdi N Neff SJ Elledge J Qin 2000 BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures Genes Dev 14 927 939 10.1101/gad.14.8.927 1:CAS:528:DC%2BD3cXivFyltrw%3D 10783165
15. YM Hendriks A Wagner H Morreau, et al.. 2004 Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance Gastroenterology 127 17 25 10.1053/j.gastro.2004.03.068 10.1053/j.gastro.2004.03.068 1:CAS:528:DC%2BD2cXmsVShsr8%3D 15236168
16. Jensen UB, Sunde L, Timshel S et al. (2009) Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0449-3
17. A Wagner Y Hendriks EJ Meijers-Heijboer, et al.. 2001 Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree J Med Genet 38 318 322 10.1136/jmg.38.5.318 10.1136/jmg.38.5.318 1:CAS:528: DC%2BD3MXkt1Cnur0%3D 11333868
18. D Ramsoekh A Wagner ME van Leerdam, et al.. 2008 A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting Gut 57 1539 1544 10.1136/gut.2008.156695 10.1136/gut.2008.156695 1:CAS:528:DC%2BD1cXhtl2gtr7F 18625694
19. M Wasielewski F Elstrodt JG Klijn EM Berns M Schutte 2006 Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines Breast Cancer Res Treat 99 97 101 10.1007/s10549-006-9186-z 10.1007/s10549-006-9186-z 1:CAS:528:DC%2BD28XnslShsLk%3D 16541312
20. P Vahteristo S Ojala A Tamminen, et al.. 2005 No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer J Med Genet 42 e22 10.1136/jmg.2004.022327 10.1136/jmg.2004.022327 1:STN:280: DC%2BD2M7ntlCjtg%3D%3D 15805151
21. DF Easton KA Pooley AM Dunning, et al.. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 1087 1093 10.1038/nature05887 10.1038/nature05887 1:CAS:528:DC%2BD2sXmvFKmurc%3D 17529967
22. DJ Hunter P Kraft KB Jacobs, et al.. 2007 A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer Nat Genet 39 870 874 10.1038/ng2075 10.1038/ng2075 1:CAS:528:DC%2BD2sXmvFKlsLg%3D 17529973
23. SN Stacey A Manolescu P Sulem, et al.. 2007 Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer Nat Genet 39 865 869 10.1038/ng2064 10.1038/ng2064 1:CAS:528:DC%2BD2sXmvFKlsL8%3D 17529974
24. SN Stacey A Manolescu P Sulem, et al.. 2008 Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer Nat Genet 40 703 706 10.1038/ng.131 10.1038/ng.131 1:CAS:528:DC%2BD1cXmsVejsL8%3D 18438407
25. S Ahmed G Thomas M Ghoussaini, et al.. 2009 Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 Nat Genet 41 585 590 10.1038/ng.354 10.1038/ng.354 1:CAS:528:DC%2BD1MXjsl2gu7c%3D 19330027
26. W Zheng J Long YT Gao, et al.. 2009 Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1 Nat Genet 41 324 328 10.1038/ng.318 1:CAS:528:DC%2BD1MXhvFKjtbo%3D 19219042